Sign In
Buy XTNT
$0.460
-0.0049 (-1.05%)
At Close: Jun 03, 2026
Xtant Medical Q1 Earnings Call Highlights
10:06pm, Friday, 15'th May 2026
Xtant Medical NYSEAMERICAN: XTNT raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter reven
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
04:20pm, Wednesday, 13'th May 2026
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
Xtant Medical Reports First Quarter 2026 Financial Results
07:00am, Wednesday, 13'th May 2026
Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive U.S. distribution agreement for Dilon Technologies' HEMOBLAST® Bel
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
08:00am, Thursday, 07'th May 2026
BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions,
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
08:00am, Wednesday, 06'th May 2026
BELGRADE, Mont., May 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions,
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
09:04am, Monday, 13'th Apr 2026
Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mon
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
08:00am, Thursday, 09'th Apr 2026
BELGRADE, Mont., April 9, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), in partnership with the Montana Governor's Office of Community Service (GOCS), today announced suppo
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
10:52am, Tuesday, 31'st Mar 2026
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
07:00am, Tuesday, 31'st Mar 2026
Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total cash of $17.3 million as of December 3
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
08:00am, Wednesday, 25'th Mar 2026
BELGRADE, Mont., March 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditi
Xtant Medical Finalizes Companion Spine Transactions
08:00am, Monday, 02'nd Mar 2026
Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Companion Spine plus related working capital adjustments BELGRADE, Mont., March 2, 2026 /PRNewswire/ -- Xta
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
08:00am, Wednesday, 25'th Feb 2026
BELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, ortho
AWM Investment Company Inc. Takes $4.88 Million Position in Xtant Medical Holdings, Inc. $XTNT
04:25am, Saturday, 13'th Dec 2025
AWM Investment Company Inc. purchased a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) in the undefined quarter, according to its most recent 13F filing with the Securities an
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
08:00am, Thursday, 11'th Dec 2025
nanOss Strata™ is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity and enhance the stimulation of cellular activity BELGRADE,
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
04:05pm, Monday, 01'st Dec 2025
BELGRADE, Mont. , Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic con
